PEPTIDES SUPPRESSING RESPIRATORY VIRUSE INFECTIONS, THEIR APPLICATION AND METHODS FOR OBTAINING Russian patent published in 2017 - IPC C07K14/47 C12N15/11 C12N5/10 C12N15/63 A61K38/17 A61P31/12 

Abstract RU 2639559 C2

FIELD: pharmacology.

SUBSTANCE: inventions relate to a peptide synthesized chemically or genetically engineered, compositions comprising such a peptide, DNA coding a polypeptide, vector incorporating such a DNA, a host cell for expression of the peptide, a peptide screening Kit, capable of suppressing a respiratory virus infection and a method for screening of a peptide capable of suppressing a respiratory virus infection. The presented peptide contains 5 or more essential amino acids, 2 or more of these essential amino acids are located in the N-terminal or C-terminal region, and the N-terminal region contains a sequence of no more than 10 amino acids from the peptide N-terminal amino acid and the C-terminal region contains a sequence of no more than 10 amino acids from the peptide C-terminal amino acid, while the peptide consists of a sequence of amino acids, at least 90% identical to SEQ ID NO: 10.

EFFECT: possibility of application of inventions to block infections of respiratory viruses such as influenza viruses or coronaviruses in the target cells for prevention and treatment of these infections.

23 cl, 10 dwg, 3 tbl, 1 ex

Similar patents RU2639559C2

Title Year Author Number
ANTIVIRAL COMPOSITION 2020
  • Granovskaya Marina Viktorovna
RU2740660C1
ANTIVIRAL COMPOSITION 2020
  • Granovskaya Marina Viktorovna
RU2740657C1
AGENT WITH ANTIVIRAL ACTIVITY AGAINST INFLUENZA A AND SARS-CoV-2 VIRUSES 2022
  • Kukes Vladimir Grigorevich
  • Engashev Sergej Vladimirovich
  • Grebennikova Tatyana Vladimirovna
  • Engasheva Ekaterina Sergeevna
  • Dorogova Olga Alekseevna
RU2796748C1
METHOD FOR PREVENTION OR TREATMENT OF CORONAVIRUS AND OTHER ACUTE RESPIRATORY VIRAL INFECTIONS 2022
  • Kruglyj Boris Igorevich
RU2794315C1
PEPTIDES WITH ANTIVIRAL ACTIVITY 2024
  • Bolatchiev Albert Dobaevich
RU2834861C1
RECOMBINANT INFLUENZA VIRUS INTENDED FOR THE PREVENTION OF COVID-19 AND INFLUENZA, METHOD OF ITS PRODUCTION AND USE 2022
  • Sergeeva Mariya Valerevna
  • Elshin Nikita Dmitrievich
  • Romanovskaya-Romanko Ekaterina Andreevna
  • Stukova Marina Anatolevna
  • Lioznov Dmitrij Anatolevich
RU2802058C1
COMBINED DRUG WITH ANTIVIRAL EFFECT AGAINST NEW SARS-COV-2 CORONAVIRUS 2021
  • Khaitov Musa Rakhimovich
  • Shilovskij Igor Petrovich
  • Kozhikhova Kseniya Vadimovna
  • Kofiadi Ilya Andreevich
  • Smirnov Valerij Valerevich
  • Koloskova Olesya Olegovna
  • Sergeev Ilya Vladimirovich
  • Trofimov Dmitrij Yurevich
  • Trukhin Viktor Pavlovich
  • Skvortsova Veronika Igorevna
RU2746362C1
PHARMACEUTICAL COMPOSITION AND MEDICINAL AGENT CONTAINING NOVEL DERIVATIVES OF FAVIPIRAVIR 2023
  • Belyi Petr Aleksandrovich
  • Lopatukhin Eduard Iurevich
  • Korolev Vladimir Lvovich
  • Zaslavskaia Kira Iakovlevna
RU2832326C1
ARTIFICIAL GENE CODING A BICISTRONIC STRUCTURE FORMED BY RECEPTOR-BINDING DOMAIN SEQUENCES OF THE GLYCOPROTEIN S OF THE SARS-COV-2 CORONAVIRUS, P2A-PEPTIDE AND GLYCOPROTEIN G VSV, RECOMBINANT PLASMID PSTEM-RVSV-STBL_RBD_SC2, PROVIDING EXPRESSION OF ARTIFICIAL GENE, AND A RECOMBINANT STRAIN OF VESICULAR STOMATITIS VIRUS RVSV-STBL_RBD_SC2, USED TO CREATE A VACCINE AGAINST SARS-COV-2 CORONAVIRUS 2020
  • Imatdinov Ilnaz Ramisovich
  • Bochkareva Mariya Dmitrievna
  • Prudnikova Elena Yurevna
  • Tishin Anton Evgenevich
  • Pyankov Oleg Viktorovich
  • Gavrilova Elena Vasilevna
  • Maksyutov Rinat Amirovich
RU2733831C1
METHOD FOR PRODUCING PROPHYLACTIC ANTIVIRAL COMPOSITION BASED ON EPIGALLOCATECHIN-3-GALLATE (EGCG) 2021
  • Lagarkova Mariya Andreevna
  • Eremeev Artem Valerevich
  • Zubkova Olga Aleksandrovna
  • Lazarev Vasilij Nikolaevich
  • Varizhuk Anna Mikhajlovna
  • Vedekhina Tatyana Sergeevna
RU2771898C1

RU 2 639 559 C2

Authors

Chzhen Botszyan

Chzhao Khantszyun

Dates

2017-12-21Published

2014-02-19Filed